These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11171995)

  • 1. Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3.
    Anderson MJ; Shelton GD; Cavenee WK; Arden KC
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1589-94. PubMed ID: 11171995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tube.
    Finckenstein FG; Davicioni E; Osborn KG; Cavenee WK; Arden KC; Anderson MJ
    Transgenic Res; 2006 Oct; 15(5):595-614. PubMed ID: 16952014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
    Sublett JE; Jeon IS; Shapiro DN
    Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors.
    Lagutina I; Conway SJ; Sublett J; Grosveld GC
    Mol Cell Biol; 2002 Oct; 22(20):7204-16. PubMed ID: 12242297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.
    Armoni M; Quon MJ; Maor G; Avigad S; Shapiro DN; Harel C; Esposito D; Goshen Y; Yaniv I; Karnieli E
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5312-24. PubMed ID: 12414908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma.
    Bennicelli JL; Edwards RH; Barr FG
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5455-9. PubMed ID: 8643596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3.
    Fredericks WJ; Galili N; Mukhopadhyay S; Rovera G; Bennicelli J; Barr FG; Rauscher FJ
    Mol Cell Biol; 1995 Mar; 15(3):1522-35. PubMed ID: 7862145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains.
    Bennicelli JL; Fredericks WJ; Wilson RB; Rauscher FJ; Barr FG
    Oncogene; 1995 Jul; 11(1):119-30. PubMed ID: 7624119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the transforming and growth suppressive activities of the PAX3-FKHR oncoprotein.
    Xia SJ; Barr FG
    Oncogene; 2004 Sep; 23(41):6864-71. PubMed ID: 15286710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene.
    Ayyanathan K; Fredericks WJ; Berking C; Herlyn M; Balakrishnan C; Gunther E; Rauscher FJ
    Cancer Res; 2000 Oct; 60(20):5803-14. PubMed ID: 11059777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.
    Barr FG
    Oncogene; 2001 Sep; 20(40):5736-46. PubMed ID: 11607823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin.
    Keller C; Hansen MS; Coffin CM; Capecchi MR
    Genes Dev; 2004 Nov; 18(21):2608-13. PubMed ID: 15520281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma.
    Kempf BE; Vogt PK
    Cell Growth Differ; 1999 Dec; 10(12):813-8. PubMed ID: 10616906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue.
    Chen BF; Chen ML; Liang DC; Huang YW; Liu HC; Chen SH
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Feb; 62(2):86-91. PubMed ID: 10063718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function.
    Keller C; Arenkiel BR; Coffin CM; El-Bardeesy N; DePinho RA; Capecchi MR
    Genes Dev; 2004 Nov; 18(21):2614-26. PubMed ID: 15489287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions.
    Collins MH; Zhao H; Womer RB; Barr FG
    Med Pediatr Oncol; 2001 Aug; 37(2):83-9. PubMed ID: 11496344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture.
    Scheidler S; Fredericks WJ; Rauscher FJ; Barr FG; Vogt PK
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9805-9. PubMed ID: 8790412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene.
    Fredericks WJ; Ayyanathan K; Herlyn M; Friedman JR; Rauscher FJ
    Mol Cell Biol; 2000 Jul; 20(14):5019-31. PubMed ID: 10866659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.
    Sorensen PH; Lynch JC; Qualman SJ; Tirabosco R; Lim JF; Maurer HM; Bridge JA; Crist WM; Triche TJ; Barr FG
    J Clin Oncol; 2002 Jun; 20(11):2672-9. PubMed ID: 12039929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?
    Anderson J; Gordon T; McManus A; Mapp T; Gould S; Kelsey A; McDowell H; Pinkerton R; Shipley J; Pritchard-Jones K;
    Br J Cancer; 2001 Sep; 85(6):831-5. PubMed ID: 11556833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.